In just a few years, weight loss jabs such as Ozempic have become an increasingly common way for people struggling with obesity to lose weight.
At the end of 2024, one in seven (14 per cent) of people in the UK had taken a GLP-1 drug such as Wegovy, Ozempic or Mounjaro themselves (5 per cent) or knew of friends or family (9 per cent) who had.
